who makes the diabetes drug copyright No Further a Mystery
• to decreased the risk of critical cardiovascular (coronary heart and blood vessel) difficulties in adults with form 2 diabetes and heart problemsThis led Novo Nordisk to perform additional study into increased dosages of semaglutide especially for weight administration.This insufficient transparency only fuels the debate about how the company b